X4 Pharmaceuticals, Inc. buy B. Riley
Start price
31.08.23
/
50%
€1.19
Target price
31.08.24
-
Performance (%)
-48.19%
End price
01.09.24
€0.62
Summary
This prediction ended on 01.09.24 with a price of €0.62. The BUY prediction by B__Riley for X4 Pharmaceuticals, Inc. performed very badly with a performance of -48.19%. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| X4 Pharmaceuticals, Inc. | -13.139% | -13.139% | -41.277% |
| iShares Core DAX® | -1.114% | 3.430% | 25.966% |
| iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
| iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
| iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by B__Riley for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at B. Riley.
Ratings data for XFOR provided by MarketBeat
In the thread Trading X4 Pharmaceuticals, Inc.
Die von B__Riley gewählte maximale Laufzeit wurde überschritten